Review of nocardial infections in France 1987 to 1990

  • P. Boiron
  • F. Provost
  • G. Chevrier
  • B. Dupont


On the basis of the numbers ofNocardia strains referred to the National Reference Center for Mycoses and Antifungal Agents (NRC), Institut Pasteur, Paris, in the period from 1987 to 1990, it was estimated that between 150 and 250 cases of nocardiosis are diagnosed in France each year. A total of 63 clinical isolates were referred to the NRC and identified asNocardia asteroides (66.7 %),Nocardia farcinica (23.8 %),Nocardia brasiliensis (3.2 %),Nocardia otitidiscaviarum (4.8 %) andNocardia carnea (1.5 %).Nocardia asteroides accounted for 71.4 % of pulmonary infections, 80.0 % of central nervous system infections and 80.0 % of systemic infections. Patients infected withNocardia farcinica died in 57.1 % of cases, compared with 17.6 % of patients infected withNocardia asteroides. Corticosteroid therapy represented a significant factor in mortality. Isolates ofNocardia asteroides revealed variable resistance, whereas isolates ofNocardia farcinica were resistant to most antimicrobial agents. Only amoxicillin/clavulanic acid, imipenem, cefoxitin, kanamycin, amikacin, minocycline and vancomycin showed activity against both species. Nocardiosis caused byNocardia farcinica may be a growing problem because of the relatively high incidence in AIDS patients and the resistance of this species to most antimicrobial agents.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Goodfellow M, Lechevalier MP Nocardioforms, genusNocardia Trevisan 1889, 9AL. In: Williams ST, Sharpe ME, Holt JG (ed): Bergey's manual of systematic bacteriology, volume 4. Williams & Wilkins, Baltimore, 1989, p. 2350–2361.Google Scholar
  2. 2.
    Pulverer G, Schall KP Pathogenicity and medical importance of aerobic and anaerobic actinomycetes. Zentralblatt für Bakteriologie 1978, 6, Supplement: 417–427.Google Scholar
  3. 3.
    Pulverer G, Schall KP Soil occurrence of pathogenic nocardiae. Zentralblatt für Bakteriologie 1978, 6, Supplement: 429–434.Google Scholar
  4. 4.
    Schaal KP, Beaman BL Clinical significance of actinomycetes. In: Goodfellow M, Mordarski M, Williams ST (ed): The biology of the actinomycetes. Academic Press, London, 1984, p. 389–424.Google Scholar
  5. 5.
    Filice GA Nocardiosis. In: Sarosi GA, Davies SF (ed): Fungal diseases of the lung. Grune & Stratton, Orlando, FL, 1986, p. 231–250.Google Scholar
  6. 6.
    Hay RJ Nocardial infections of the skin. Journal of Hygiene 1983, 91: 385–391.PubMedGoogle Scholar
  7. 7.
    Smego RA, Gallis HA The clinical spectrum ofNocardia brasiliensis infection in the United States. Reviews of Infectious Diseases 1984, 6: 164–180.PubMedGoogle Scholar
  8. 8.
    Rippon JW Medical mycology. The pathogenic fungi and the pathogenic actinomycetes. Saunders, Philadelphia, 1988, p. 80–103.Google Scholar
  9. 9.
    Curry WA Human nocardiosis. A clinical review with selected case reports. Archives of International Medicine 1980, 140: 818–826.CrossRefGoogle Scholar
  10. 10.
    Harris GK Nocardiosis: a literature review and a case report ofNocardia asteroides infection. American Journal of Medical Technology 1980, 46: 44–48.PubMedGoogle Scholar
  11. 11.
    Kim J, Minamoto GR, Grieco MH Nocardial infection as a complication of AIDS: report of six cases and review. Reviews of Infectious Diseases 1991, 13: 624–629.PubMedGoogle Scholar
  12. 12.
    Beaman BL, Sugar AM Interaction ofNocardia in naturally acquired infection in animals. Journal of Hygiene 1983, 91: 393–419.PubMedGoogle Scholar
  13. 13.
    Mishra SK, Gordon RE, Barnett DA Identification of nocardiae and streptomycetes of medical importance. Journal of Clinical Microbiology 1980, 11: 728–736.PubMedGoogle Scholar
  14. 14.
    Lerner PI Nocardia species. In: Mandell GL, Douglas RG, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, Edinburgh, 1990, p. 1926–1932.Google Scholar
  15. 15.
    Gonzalez-Ochoa A Virulence of nocardiae. Canadian Journal of Microbiology 1973, 19: 901–904.PubMedGoogle Scholar
  16. 16.
    Murray JF, Finegold SM, Froman, Will DW The changing spectrum of nocardiosis, a review and presentation of nine cases. American Review of Respiratory Diseases 1961, 83: 315–320.Google Scholar
  17. 17.
    Palmer OL, Harvey RL, Wheeler JK Diagnostic and therapeutic considerations inNocardia asteroides infection. Medicine 1974, 53: 391–401.PubMedGoogle Scholar
  18. 18.
    Beaman BL, Burnside J, Edwards B, Causey W Nocardial infections in the United States, 1972–1974. Journal of Infectious Diseases 1976, 134: 286–289.PubMedGoogle Scholar
  19. 19.
    Staneck JL, Roberts GD Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Applied Microbiology 1974, 28: 226–231.PubMedGoogle Scholar
  20. 20.
    Minnikin DE, Alshamaony L, Goodfellow M Differentiation ofMycobacterium, Nocardia and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. Journal of General Microbiology 1975, 38: 200–204.Google Scholar
  21. 21.
    Gordon MA Aerobic pathogenicActinomycetaceae. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 249–262.Google Scholar
  22. 22.
    Boiron P, Provost F Characterization ofNocardia, Rhodococcus andGordona species by in vitro susceptibility testing. Zentralblatt für Bakteriologie 1990, 274: 203–213.Google Scholar
  23. 23.
    McNeil MM, Brown JM, Jarvis WR, Ajello L Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Reviews of Infectious Diseases 1990, 12: 778–783.PubMedGoogle Scholar
  24. 24.
    Tsukamura M Numerical analysis of the taxonomy of nocardiae and rhodococci. Microbiology and Immunology 1982, 26: 1101–1119.PubMedGoogle Scholar
  25. 25.
    Yano I, Imaeda T, Tsukamura M Characterization ofNocardia nova. International Journal of Systematic Bacteriology 1990, 40: 170–174.Google Scholar
  26. 26.
    Lechevalier MP The taxonomy of the genusNocardia: some light at the end of the tunnel. In: Goodfellow M, Brownell GH, Serrano JA (ed): The biology of the nocardiae. Academic Press, London, 1976, p. 1–38.Google Scholar
  27. 27.
    Wallace RJ, Tsukamura M, Brown BA, Brown J, Steingrube VA, Zhang Y, Nash DR Cefotaxime-resistantNocardia asteroides strains are isolates of the controversial speciesNocardia farcinica. Journal of Clinical Microbiology 1990, 28: 2726–2732.PubMedGoogle Scholar
  28. 28.
    Schaal KP Actinomycetes as human pathogens. In: Okami Y, Beppu T, Ogawara H (ed): Biology of actinomycetes, 1988. Japan Scientific Societies Press, Tokyo, 1988, p. 277–282.Google Scholar
  29. 29.
    Berd D Nocardia brasiliensis infections in the United States: a report of nine cases and a review of the literature. American Journal of Clinical Pathology 1973, 60: 254–258.PubMedGoogle Scholar
  30. 30.
    Schaal KP, Bickenbach H Soil occurrence of pathogenic nocardiae. Zentralblatt für Bakteriologie 1978, 6, Supplement: 429–434.Google Scholar
  31. 31.
    Holtz HA, Lavery DP, Kapila R Actinomycetales infection in the acquired immunodeficiency syndrome. Annals of Internal Medicine 1985, 102: 203–205.PubMedGoogle Scholar
  32. 32.
    Presant CA, Wiernik PH, Serpick AA Factors affecting survival in nocardiosis. American Review of Respiratory Diseases 1973, 108: 1444–1448.Google Scholar
  33. 33.
    Smego RA, Moeller MB, Gallis HA Trimethoprim-sulfamethoxazole therapy forNocardia infections. Archives of internal Medicine 1983, 143: 711–718.CrossRefPubMedGoogle Scholar
  34. 34.
    Schaal KP, Schütt-Gerowitt H, Goldmann A In vitro and in vivo studies on the efficacy of various antimicrobial agents in the treatment of human nocardiosis. In: Szabo G, Biro S, Goodfellow M (ed): Biological, biochemical and biomedical aspects of actinomycetes. Akadémial Kiado, Budapest, 1985, p. 619–633.Google Scholar
  35. 35.
    Boiron P, Provost F In vitro susceptibility ofNocardia spp. and its taxonomic implication. Journal of Antimicrobial Chemotherapy 1988, 22: 623–630.PubMedGoogle Scholar
  36. 36.
    Gombert ME Susceptibility ofNocardia asteroides to various antibiotics including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, N-formimidoyl thienamycin. Antimicrobial Agents and Chemotherapy 1982, 21: 1011–1012.PubMedGoogle Scholar
  37. 37.
    Gombert ME, Aulicino TM, duBouchet L, Berkowitz LR Susceptibility ofNocardia asteroides to new quinolones and β-lactams. Antimicrobial Agents and Chemotherapy 1987, 31: 2013–2014.PubMedGoogle Scholar
  38. 38.
    Berkey P, Moore D, Rolston K In vitro susceptibility ofNocardia species to newer antimicrobial agents. Antimicrobial Agents and Chemotherapy 1988, 32: 1078–1079.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1992

Authors and Affiliations

  • P. Boiron
    • 1
  • F. Provost
    • 1
  • G. Chevrier
    • 1
  • B. Dupont
    • 1
  1. 1.Unité de MycologieInstitut PasteurParis Cedex 15France

Personalised recommendations